Junying Chen

Junying Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Therapeutic Advances in Respiratory Disease
Verified
Journal Article
Open access
JCJunying Chen
Junying Chen
HYHan Yang
Han Yang
XLXiao-Dan Lin
Xiao-Dan Lin
HYHong Yang
Hong Yang
JWJing Wen
Jing Wen
KLKongjia Luo
Kongjia Luo
Background: Although electromagnetic navigation bronchoscopy (ENB) is highly sensitive in the diagnosis of peripheral pulmonary nodules (PPNs), its diagnostic yield for subgroups of smaller PPNs is under evaluation. Objectives: Diagnostic yield evaluation of biopsy using ENB for PPNs <2 cm. Design: The diagnostic yield, sensitivity, specificity, positive predictive value, and negative predictive value of the ENB-mediated biopsy for PPNs were evaluated. Methods: Patients who had PPNs with diameters <2 cm and underwent ENB-mediated biopsy between May 2015 and February 2020 were consecutively enrolled. The final diagnosis was made via pathological examination after surgery. Results: A total of 82 lesions from 65 patients were analyzed. The median tumor size was 11 mm. All lesions were subjected to ENB-mediated biopsy, of which 29 and 53 were classified as malignant and benign, respectively. Subsequent segmentectomy, lobectomy, or wedge resection, following pathological examinations were performed on 64 nodules from 57 patients. The overall sensitivity, specificity, positive predictive value, and negative predictive value for nodules <2 cm were 53.3%, 91.7%, 92.3%, and 51.2%, respectively. The receiver operating curve showed an area under the curve of 0.721 ( p < 0.001). Additionally, the sensitivity, specificity, positive predictive value, and negative predictive value were 62.5%, 100%, 100%, and 42.9%, respectively, for nodules with diameters equal to or larger than 1 cm; and 30.8%, 86.7%, 66.7%, and 59.1%, respectively, for nodules less than 1 cm. In the subgroup analysis, neither the lobar location nor the distance of the PPNs to the pleura affected the accuracy of the ENB diagnosis. However, the spiculated sign had a negative impact on the accuracy of the ENB biopsy ( p = 0.010). Conclusion: ENB has good specificity and positive predictive value for diagnosing PPNs <2 cm; however, the spiculated sign may negatively affect ENB diagnostic accuracy. In addition, the diagnostic reliability may only be limited to PPNs equal to or larger than 1 cm.

5 August 2023 in Clinical Drug Investigation
Verified
Journal Article
Closed access
PDF file
SLShijie Lu
Shijie Lu
YLYake Lou
Yake Lou
YRYi Rong
Yi Rong
ZHZirui Huang
Zirui Huang
XLXiaodan Lin
Xiaodan Lin
KLKongjia Luo
Kongjia Luo

4 December 2023 in International Journal of Surgery
Verified
Journal Article
Open access
JCJunying Chen
Junying Chen
HJHeng Jiao
Heng Jiao
BZBin Zheng
Bin Zheng
TZTaidui Zeng
Taidui Zeng
HWHao Wang
Hao Wang
JFJianhua Fu
Jianhua Fu
Background: Carbon dioxide gas-induced pneumoperitoneum might be the reason for the shorter postoperative survival of patients with malignant tumors. Whether CO2 gas-induced pneumothorax has unfavorable impacts on the surgical and oncological outcomes of minimally invasive esophagectomy remains unclear. Methods: Between 2010 and 2016, a total of 998 patients with squamous cell carcinoma of the esophagus who received video-assisted surgery were registered from three large-volume medical centers. The overall survival (OS) and disease-free survival (DFS) were compared after using propensity score-matched and inverse probability-weighted methods. In addition, the tumor-relapse state was evaluated, and the relapse pattern was compared. Results: A total of 422 and 576 minimally invasive esophagectomies with intraoperative one-lung ventilation and CO2-induced pneumothorax were enrolled, respectively. The 5-year OS and DFS were similar between the CO2-induced pneumothorax (64.2% and 64.7%) and one-lung ventilation (65.3% and 62.4%) groups following propensity matching. The inverse probability weighting revealed similarly equal survival results in the two groups. The 5-year relapse rates were 35.1% and 30.6% in the one-lung ventilation and CO2-induced pneumothorax groups, respectively. Moreover, the relapse patterns were not significantly different between the two groups. Conclusion: The results of this study suggested that the use of intraoperative one-lung ventilation and CO2-induced pneumothorax have similar oncological outcomes; therefore, the two methods are both viable options in esophagectomy.

12 January 2026 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
BCBaoqing Chen
Baoqing Chen
JCJunying Chen
Junying Chen
SWSifen Wang
Sifen Wang
KBKunhao Bai
Kunhao Bai
ZLZimeng Li
Zimeng Li
MXMian Xi
Mian Xi
Purpose: Chemoradiotherapy (CRT) combined with anti-PD-1 for locally advanced esophageal squamous cell carcinoma (ESCC) has shown promising efficacy but lack the predictive biomarkers to identify patients who could benefit from this therapy. The predictive value of serum cytokines in ESCC patients remains unclear. We aimed to identify cytokine-based biomarkers for treatment response and survival in this setting. Experimental Design: Exploratory analyses were conducted on 81 ESCC patients from two phase II trials treated with CRT plus toripalimab, with validation in an independent prospective cohort (n=61). Nineteen serum cytokines were assessed at baseline, during, and post-CRT plus anti-PD-1 antibody. A cytokine-based risk score model (CYTOscore) was constructed. Multi-omics profiling including RNA-seq, WES, and spatial transcriptomics were performed to explore potential differences in tumor microenvironments. Results: Cox analyses identified Interleukin-8 (IL-8), C-C motif chemokine ligand 3 (CCL3), and C-C motif chemokine ligand 4 (CCL4) as potential biomarkers and were used to constructed the CYTOscore. Patients stratified by baseline CYTOscore showed significantly longer OS (HR, 0.31; 95%CI, 0.16-0.62; p= 0.00045) and PFS (HR, 0.33; 95%CI, 0.17-0.62; p= 0.00036) in the low-risk group, which also had higher complete response (CR) rates (66% vs 35%, p=0.014). These finding were next validated in the external cohort, with the low-risk group demonstrating higher CR rates (66% vs 27%, p=0.039) and longer OS (HR 0.30, 95% CI 0.09-0.99, p=0.045). A nomogram incorporating baseline CYTOscore and clinical characteristics showed promising predictive accuracy in 1-, 2-, and 3-year OS (AUC=0.77, 0.78, and 0.76). Multi-omics analysis revealed enriched interferon-γ/α signaling in B cells within low-risk patients. Conclusions: The CYTOscore based on IL-8, CCL3, and CCL4 effectively predicts treatment response and survival in ESCC patients receiving CRT plus anti-PD-1 antibody.

1 October 2025 in Cancer Reports
Verified
Journal Article
Open access
JLJin‐Bo Li
Jin‐Bo Li
LZLi‐Hong Zhang
Li‐Hong Zhang
CLChang‐Sen Leng
Chang‐Sen Leng
JCJunying Chen
Junying Chen
JFJianhua Fu
Jianhua Fu
Background: Lymphovascular invasion (LVI) adversely affects the survival of pT1b esophageal squamous cell carcinoma (ESCC). It is hypothesized that a modified stage classification of pT1b ESCC based on LVI may facilitate multidisciplinary therapy in LVI‐positive patients. Aims: The study aims to investigate the impact of LVI on pathological nodal classification for pT1b ESCC. Methods and Results: Surgically resected pT1b ESCC patients in Sun Yat‐sen University Cancer Center between 2008 and 2018 were retrospectively reviewed. Tumor sections were re‐assessed for LVI by gastrointestinal pathologists. The associations between patient survival and LVI were evaluated by the Log‐rank method. A multivariate Cox regression model was applied to identify the impact of LVI on survival. Prognostic performance was assessed by Harrell's C ‐index. A total of 424 cases with the pT1b stage were included. The risk of LVI was significantly higher in patients with nodal positive status ( p < 0.001) and larger tumor size ( p = 0.033). The 5‐year OS for LVI+ patients were 50.3% versus 78.0% for LVI− ( p < 0.001). Multivariable analyses suggested that LVI ( p = 0.021) and pN ( p = 0.016) stages were two independent adverse prognostic factors in pT1b patients. When classifying LVI+ as an independent subgroup into the pN category, the modified pN staging system demonstrated a superior prognostic performance ( p < 0.001). Conclusion: Tumors with LVI should be defined as a separate subclassification to accurately classify the prognostic category in pT1b patients. Further studies are required to investigate multidisciplinary therapies for LVI+ pT1b patients.